Article Text

PDF

Mitral valve disease, systemic embolism and anticoagulants
  1. H. A. Fleming,
  2. Sheila M. Bailey

    Abstract

    Over a period of 9½ years patients in East Anglia with mitral valve disease not requiring immediate surgery have been followed.

    There has been a high incidence of systemic embolism before the patients are referred.

    Long-term treatment with anticoagulants appears to offer a good degree of protection to these patients and, provided the control of the treatment is good, the risks arising from it are small and less than the risks of embolism.

    Statistics from Altmetric.com

    Footnotes

    • * Presented to the East Anglian Meeting of the Royal College of Physicians in Cambridge on Saturday, 21 March 1970.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.